Checkpoint immunotherapy is a breakthrough in cancer treatment — and it may also promote HIV remission.
POZ news story
New studies add to the evidence that immune checkpoint inhibitors are safe and effective for people with HIV and cancer. What’s more, a growing body of research suggests that this type of immunotherapy could also play a role in a functional cure for HIV.
Checkpoint inhibitors, the most widely used type of immunotherapy, are a breakthrough in treatment for several types of cancer. These monoclonal antibodies interfere with receptors on immune cells that regulate immune response. For example, drugs that block PD-1 or its binding partner, PD-L1 — such as Keytruda (pembrolizumab) — can restore lost T-cell activity, while those that block CTLA-4 — such as Yervoy (ipilimumab) — promote T-cell multiplication.
Read the full news story here.
Source : POZ
Related HIV and Co-Infections News
-
[CROI 2026] TheBodyPro: Why chronic inflammation drives multimorbidity in people with HIV, despite viral suppression
-
Medical Xpress: Norway’s ‘Oslo patient’ reaches HIV remission after rare stem cell transplant donated by brother
-
UNC School of Medicine: Researchers demonstrate drug’s effectiveness in drawing out dormant HIV from immune cells
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.